Tuesday, August 11, 2026

The American Economic Liberties Project released a report demanding that federal and state regulators prohibit health insurers from using prior authorization for a wide range of services. The report argues that the practice restricts access to care, adds administrative waste, and serves primarily as a profit-protection tool. While not yet policy, this adds weight to an existing national debate, with some states already pursuing PA reform legislation. A parallel story from STAT+ notes that despite payer promises to reduce PA volume, the related administrative savings are shrinking, suggesting the economic justification for the practice is weakening. Watch for state-level regulatory activity; comment periods on proposed PA rules in New York and Rhode Island close later this year.

Rural health providers in Louisiana are battling each other over payment allocations as the state prepares to implement significant Medicaid cuts. The dispute centers on how limited funding will be distributed among hospitals, clinics, and FQHCs. With overall Medicaid expenditures expected to fall, providers are positioning to protect their share, a scenario likely to repeat in other states facing budget pressure. Rural clinics should review their state's Medicaid budget proposals and projected patient-mix shifts. The comment period for Louisiana's State Plan Amendment is the next procedural step to monitor.

A federal district court ruled against the manufacturer of Relizorb and Medicare beneficiaries seeking higher reimbursement under the gap-filling methodology for durable medical equipment. The decision affirms CMS's payment calculation, closing a legal challenge that sought to increase payment rates for the enzyme cartridge used with enteral feeding systems. This sets a precedent limiting challenges to CMS's DME pricing methodologies, which rely on supplier-submitted pricing data. For practices dispensing DME, the ruling reinforces that payment rates are unlikely to be adjusted upward via litigation; focus instead on accurate cost reporting during the gap-filling data collection period.

A federal judge dismissed a pharmaceutical industry lawsuit attempting to block South Dakota's 2025 law that mandates transparency and discounts on prescription drugs. The ruling affirms the state's authority to regulate drug pricing within its Medicaid and public employee plans, setting a legal precedent other states may follow. This loss for the pharmaceutical lobby signals growing judicial tolerance for aggressive state-level drug pricing interventions. The decision does not immediately change commercial payer contracts but reinforces a regulatory trend where states are acting as laboratories for cost-control policies that may later scale nationally.

WVU Medicine will incorporate the 25-bed Fulton County Medical Center in Pennsylvania, marking another rural hospital acquisition by a major academic health system. The move follows a pattern of rural facilities seeking financial stability through affiliation with larger networks to secure better payer contracts and access capital. For independent practices in the region, this signals a shift in referral patterns and potentially stricter network requirements from the dominant local provider. The deal highlights the continued consolidation pressure on rural healthcare infrastructure, which directly impacts patient flow and negotiating leverage for surrounding clinics.